{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T12:15:58Z","timestamp":1758629758207},"reference-count":32,"publisher":"Biomedical Research Press","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed. Res."],"published-print":{"date-parts":[[2013]]},"DOI":"10.2220\/biomedres.34.13","type":"journal-article","created":{"date-parts":[[2013,2,19]],"date-time":"2013-02-19T23:29:47Z","timestamp":1361316587000},"page":"13-21","source":"Crossref","is-referenced-by-count":9,"title":["Hypoxia affects in vitro growth of newly established cell lines from patients with malignant pleural mesothelioma"],"prefix":"10.2220","volume":"34","author":[{"given":"Houman","family":"Goudarzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Hida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Takano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Teramae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Iizasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-ichi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1059","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Aoe K, Hiraki A, Murakami T, Toyooka S, Shivapurkar N, Gazdar AF, Sueoka N, Taguchi K, Kamei T, Takeyama H, Sugi K and Kishimoto T (2006) Infrequent existence of simian virus 40 large T antigen DNA in malignant mesothelioma in Japan. Cancer Sci 97, 292-295.","DOI":"10.1111\/j.1349-7006.2006.00171.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Bar EE, Lin A, Mahairaki V, Matsui W and Eberhart CG (2010) Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol 177, 1491-1502.","DOI":"10.2353\/ajpath.2010.091021"},{"key":"3","unstructured":"3. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy-Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 59, 5863-5870."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Gazdar AF and Carbone M (2003) Molecular pathogenesis of malignant mesothelioma and its relationship to simian virus 40. Clin Lung Cancer 5, 177-181.","DOI":"10.3816\/CLC.2003.n.031"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Graeber TG, Osmanian C, Jacks T, Housman DE, Koch CJ, Lowe SW and Giaccia AJ (1996) Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91.","DOI":"10.1038\/379088a0"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Graziani I, Eliasz S, De Marco MA, Chen Y, Pass HI, De May RM, Strack PR, Miele L and Bocchetta M (2008) Opposite effects of Notch-1 and Notch-2 on mesothelioma cell survival under hypoxia are exerted through the Akt pathway. Cancer Res 68, 9678-9685.","DOI":"10.1158\/0008-5472.CAN-08-0969"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2, 38-47.","DOI":"10.1038\/nrc704"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ho L, Sugarbaker DJ and Skarin AT (2001) Malignant pleural mesothelioma. Cancer Treat Res 105, 327-373.","DOI":"10.1007\/978-1-4615-1589-0_13"},{"key":"9","unstructured":"9. Horai T, Imamura F, Nakae T, Nakamura S, Mukai M, Shinkai K, Higashino K and Akedo H (1992) Interactions of lung cancer cells with the human mesothelial cell monolayer:An in vitro model for cancer invasion. Jpn J Clin Oncol 22, 67-72."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Huang H, Reis R, Yonekawa Y, Lopes JM, Kleihues P and Ohgaki H (1999) Identification in human brain tumors of DNA sequences specific for SV40 large T antigen. Brain Pathol 9, 33-42.","DOI":"10.1111\/j.1750-3639.1999.tb00207.x"},{"key":"11","unstructured":"11. Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson A, Roggli V, Travis WD and Wick M (2012) Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 Update of the consensus statement from the international mesothelioma interest group. Arch Pathol Lab Med, in press (doi:10.5858\/arpa.2012-0214-OA)"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Kamp DW (2009) Asbestos-induced lung diseases: an update.Transl Res 153, 143-152.","DOI":"10.1016\/j.trsl.2009.01.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kitamura F, Araki S, Suzuki Y, Yokoyama K, Tanigawa T and Iwasaki R (2002) Assessment of the mutations of p53 suppressor gene and Ha- and Ki-ras oncogenes in malignant mesothelioma in relation to asbestos exposure: a study of 12 American patients. Ind Health 40, 175-181.","DOI":"10.2486\/indhealth.40.175"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Klabatsa A, Sheaff MT, Steele JP, Evans MT, Rudd RM and Fennell DA (2006) Expression and prognostic significance of hypoxia-inducible factor 1alpha (HIF-1alpha) in malignant pleural mesothelioma (MPM). Lung Cancer 51, 53-59.","DOI":"10.1016\/j.lungcan.2005.07.010"},{"key":"15","unstructured":"15. Kobayashi M, Takeuchi T and Ohtsuki Y (2008) Establishment of three novel human malignant pleural mesothelioma cell lines: Morphological and cytogenetical studies and EGFR mutation status. Anticancer Res 28, 194-208."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Lee AY, Raz DJ, He B and Jablons DM (2007) Update on the molecular biology of malignant mesothelioma. Cancer 109, 1454-1461.","DOI":"10.1002\/cncr.22552"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Li Y and Heldin P (2001) Hyaluronan production increases the malignant properties of mesothelioma cells. Br J Cancer 85, 600-607.","DOI":"10.1054\/bjoc.2001.1922"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. López-Ríos F, Chuai S, Flores R, Shimizu S, Ohno T, Wakahara K, Illei PB, Hussain S, Krug L, Zakowski MF, Rusch V, Olshen AB and Ladanyi M (2006) Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16\/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction. Cancer Res 66, 2970-2979.","DOI":"10.1158\/0008-5472.CAN-05-3907"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM and Suo Z (2011) Prostate cancer cell lines under hypoxia exhibit greater stem-like properties. PLoS One 6, e29170.","DOI":"10.1371\/journal.pone.0029170"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Macheda ML, Rogers S and Best JD (2005) Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202, 654-662.","DOI":"10.1002\/jcp.20166"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Magee JA, Piskounova E and Morrison SJ (2012) Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 21, 283-296.","DOI":"10.1016\/j.ccr.2012.03.003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Mor O, Yaron P, Huszar M, Yellin A, Jakobovitz O, Brok-Simoni F, Rechavi G and Reichert N (1997) Absence of p53 mutations in malignant mesotheliomas. Am J Respir Cell Mol Biol 16, 9-13.","DOI":"10.1165\/ajrcmb.16.1.8998073"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Murayama T, Takahashi K, Natori Y and Kurumatani N (2006) Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49, 1-7.","DOI":"10.1002\/ajim.20246"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Nakataki E, Yano S, Matsumori Y, Goto H, Kakiuchi S, Muguruma H, Bando Y, Uehara H, Hamada H, Kito K, Yokoyama A and Sone S (2006) Novel orthotopic implantation model of human malignant pleural mesothelioma (EHMES-10 cells) highly expressing vascular endothelial growth factor and its receptor. Cancer Sci 97, 183-191.","DOI":"10.1111\/j.1349-7006.2006.00163.x"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Nasreen N, Mohammed KA, Ward MJ and Antony VB (1999) Mycobacterium-induced transmesothelial migration of monocytes into pleural space: role of intercellular adhesion molecule-1 in tuberculous pleurisy. J Infect Dis 180, 1616-1623.","DOI":"10.1086\/315057"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Semenza GL (2000) Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol 35, 71-103.","DOI":"10.1080\/10409230091169186"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Vaupel P, Mayer A and Hockel M (2004) Tumor hypoxia and malignant progression. Methods Enzymol 381, 335-354.","DOI":"10.1016\/S0076-6879(04)81023-1"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Vaupel P and Mayer A (2007) Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26, 225-239.","DOI":"10.1007\/s10555-007-9055-1"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Warburg O (1956) On the origin of cancer cells. Science 123, 309-314.","DOI":"10.1126\/science.123.3191.309"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Yanagihara K, Tsumuraya M, Takigahira M, Mihara K, Kubo T, Ohuchi K and Seyama T (2010) An orthotopic implantation mouse model of human malignant pleural mesothelioma for in vivo photon counting analysis and evaluation of the effect of S-1 therapy. Int J Cancer 126, 2835-2846.","DOI":"10.1002\/ijc.25002"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Yeung TM, Gandhi SC and Bodmer WF (2011) Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells. Proc Natl Acad Sci USA 108, 4382-4387.","DOI":"10.1073\/pnas.1014519107"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Yoshikawa K, Hamada J, Tada M, Kameyama T, Nakagawa K, Suzuki Y, Ikawa M, Hassan NM, Kitagawa Y and Moriuchi T (2010) Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells. Biomed Res 31, 401-411.","DOI":"10.2220\/biomedres.31.401"}],"container-title":["Biomedical Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T07:17:22Z","timestamp":1714979842000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/biomedres\/34\/1\/34_13\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.2220\/biomedres.34.13","relation":{},"ISSN":["0388-6107","1880-313X"],"issn-type":[{"value":"0388-6107","type":"print"},{"value":"1880-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013]]}}}